Champions Oncology CSBR
NASDAQ CSBR
$4.84 -0.06 (-1.22%)
As of: Oct 14, 2026 · 1:14 PM EDT

Champions Oncology (CSBR) Capital Expenditures (2010 - 2026)

Updated

Champions Oncology (CSBR) recorded Capital Expenditures of $55,000 in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 19.6% from $46,000 a year earlier but down 77.0% from the prior quarter.

Analysis

Champions Oncology (CSBR) Capital Expenditures (2010 - 2026) Analysis & Trends

On a TTM basis, Champions Oncology's Capital Expenditures came in at $573,000 as of Jul 31, 2026, up 31.7% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $564,000, up 45.0% from FY2025.

  • Annual Capital Expenditures has a five-year compound annual growth rate of -29.7% (FY2021 to FY2026).
  • Across earlier fiscal years, Capital Expenditures came in at $389,000 in FY2025 (-53.5%), $836,000 in FY2024 (-70.9%), $2.87 million in FY2023 (+20.5%) and $2.38 million in FY2022 (-27.3%).
  • Quarterly Capital Expenditures has ranged from -$3,000 in fiscal Q4 2024 to $760,000 in fiscal Q4 2023 over the past five years.
  • On a year-over-year basis, Capital Expenditures rose in three of the last six quarters, with growth averaging 20.7%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 157.4% in fiscal Q2 2026, against a decline of 87.8% in fiscal Q3 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $239,000 (Q4 2026), $37,000 (Q3 2026) and $242,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Iqvia Holdings 43.53 Bn 35.24 Bn 1.44 Bn 198.00 Mn
2 Medpace Holdings 17.35 Bn 15.41 Bn 201.64 Mn 23.91 Mn
3 Charles River Laboratories International 14.58 Bn 13.78 Bn 363.37 Mn 31.11 Mn
4 Icon 13.22 Bn 10.33 Bn 479.29 Mn 42.42 Mn
5 Fortrea Holdings 2.04 Bn 1.42 Bn 139.20 Mn 9.00 Mn
6 Ginkgo Bioworks Holdings 732.71 Mn -29.38 Mn 18.44 Mn 2.62 Mn
7 Evotec SE 504.29 Mn -1.11 Bn - -
8 Champions Oncology 67.26 Mn 42.35 Mn 7.70 Mn 55,000.00
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn 55,941.69
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn 637,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 55,000.00
Apr 30, 2026 239,000.00
Jan 31, 2026 37,000.00
Oct 31, 2025 242,000.00
Jul 31, 2025 46,000.00
Apr 30, 2025 253,000.00
Jan 31, 2025 42,000.00
Oct 31, 2024 94,000.00
Apr 30, 2024 -3,000.00
Jan 31, 2024 92,000.00
Oct 31, 2023 79,000.00
Jul 31, 2023 668,000.00
Apr 30, 2023 760,000.00
Jan 31, 2023 754,000.00
Oct 31, 2022 604,000.00
Jul 31, 2022 754,000.00
Apr 30, 2022 506,000.00
Jan 31, 2022 405,000.00
Oct 31, 2021 566,000.00
Jul 31, 2021 907,000.00
API Access

Champions Oncology Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CSBR&period=max&api_key=YOUR_API_KEY